Literature DB >> 19802990

Assay of ceftazidime in biological fluids using high-pressure liquid chromatography.

J Ayrton1.   

Abstract

An HPLC method for the assay of ceftazidime in plasma and urine is described. It is sensitive, accurate and reproducible; results show good agreement with those obtained using microbiological assay.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 19802990     DOI： 10.1093/jac/8.suppl_b.227

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  13 in total

1.  Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.

Authors:  A Hedman; Y Adan-Abdi; G Alvan; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

2.  Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.

Authors:  R A Walstad; L Aanderud; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Cephalosporin assays.

Authors:  J B Ward; P B Harper
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.

Authors:  R A Walstad; K Dahl; K B Hellum; E Thurmann-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.

Authors:  J L Gaillard; P Cahen; C Delacourt; C Silly; M Le Bourgeois; C Coustère; J de Blic; G Lenoir; P Scheinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

6.  Pharmacokinetics of ceftazidime in patients with biliary tract disease.

Authors:  R A Walstad; J N Wiig; E Thurmann-Nielsen; T B Halvorsen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients.

Authors:  B Ljungberg; I Nilsson-Ehle
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.

Authors:  B Ljungberg; I Nilsson-Ehle
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates.

Authors:  S M Harding; P B Harper
Journal:  Infection       Date:  1983       Impact factor: 3.553

10.  CSF pharmacokinetics of ceftazidime in neurosurgical patients with an external ventriculostomy.

Authors:  U Fuhr; S Harder; S Häfner; D Rosenthal; R Lorenz; A H Staib
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.